NFL Biosciences S.A.
ALNFL.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €1,914 | €2,338 | €1,054 | €3,040 |
| Short-Term Investments | €200 | €191 | €161 | €165 |
| Receivables | €1,058 | €1,109 | €742 | €220 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €0 | €0 | €0 | €0 |
| Total Curr. Assets | €3,340 | €3,821 | €2,258 | €3,559 |
| Property Plant & Equip (Net) | €125 | €9 | €2 | €2 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €145 | €141 | €136 | €124 |
| Long-Term Investments | €0 | €0 | €0 | -€165 |
| Tax Assets | €0 | €0 | €0 | €165 |
| Other NC Assets | €168 | €0 | €0 | €0 |
| Total NC Assets | €438 | €150 | €138 | €126 |
| Other Assets | -€168 | €0 | €0 | €0 |
| Total Assets | €3,610 | €3,971 | €2,395 | €3,685 |
| Liabilities | – | – | – | – |
| Payables | €1,148 | €2,164 | €1,187 | €120 |
| Short-Term Debt | €41 | €23 | €83 | €0 |
| Tax Payable | €255 | €204 | €208 | €120 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | €1,190 | €1,230 | €73 | €0 |
| Total Curr. Liab. | €2,633 | €3,621 | €1,551 | €186 |
| LT Debt | €20 | €39 | €62 | €0 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €1,190 | €1,191 | €73 | €127 |
| Total NC Liab. | €1,210 | €1,230 | €135 | €0 |
| Other Liabilities | €0 | -€1,230 | -€1,270 | €0 |
| Cap. Leases | €0 | €0 | €0 | €0 |
| Total Liabilities | €2,633 | €3,621 | €1,551 | €398 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €978 |
| Common Stock | €295 | €243 | €157 | €157 |
| Retained Earnings | -€2,081 | -€7,167 | -€3,422 | -€978 |
| AOCI | €0 | €0 | €0 | -€978 |
| Other Equity | €0 | €0 | €0 | €0 |
| Total Equity | €976 | €350 | €844 | €3,287 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €3,610 | €3,971 | €2,395 | €3,685 |
| Net Debt | -€1,853 | -€2,276 | -€908 | -€3,040 |